Citation Impact
Citing Papers
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
2013
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney
2002 StandoutNobel
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
1999
Bacteriocins: developing innate immunity for food
2005 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Ulcerative Colitis
2011 Standout
Development of the Human Infant Intestinal Microbiota
2007 Standout
Low counts of Faecalibacterium prausnitzii in colitis microbiota
2009
Human Genetics Shape the Gut Microbiome
2014 Standout
The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics
2001
Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease
2002
Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products
1995
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
2014
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
2003
Molecular Characterization of Rectal Mucosa-Associated Bacterial Flora in Inflammatory Bowel Disease
2005
Crohn's disease
2012 Standout
Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health
2016 Standout
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
2005
Spontaneous Pneumothorax
2000 Standout
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
2011
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Alternative Drug Delivery Approaches for the Therapy of Inflammatory Bowel Disease
2007
Metagenomic biomarker discovery and explanation
2011 Standout
Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion
1994
Gut microbiome and health: mechanistic insights
2022 Standout
Health benefits of probiotics: are mixtures more effective than single strains?
2011
Inflammation and Colon Cancer
2010 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Analysis of bacterial bowel communities of IBD patients: What has it revealed?
2008
Specificities of the fecal microbiota in inflammatory bowel disease
2006
Necrotizing Enterocolitis
2011 Standout
Pre-, pro- and synbiotics
2001
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
With or without you — Proteomics with or without major plasma/serum proteins
2016
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
2011 Standout
Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease
2007
Adaptation of Bacteria to the Intestinal Niche: Probiotics and Gut Disorder
2001
Gut flora in health and disease
2003 Standout
Drugs from hidden bugs: their discovery via untapped resources
2008
Evolving knowledge and therapy of inflammatory bowel disease
2006
Defect in SHAP-Hyaluronan Complex Causes Severe Female Infertility
2001
Molecular inventory of faecal microflora in patients with Crohn's disease
2004
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Mononuclear Leukocytes Bind to Specific Hyaluronan Structures on Colon Mucosal Smooth Muscle Cells Treated with Polyinosinic Acid:Polycytidylic Acid
2003 Standout
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
2005 Standout
Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice
2002
Field-resolved infrared spectroscopy of biological systems
2020 StandoutNatureNobel
Dysbiosis in inflammatory bowel disease
2003
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
2006
Antibiotic therapy attenuates colitis in interleukin 10 gene–deficient mice
2000
Inactivation of α 1 -Proteinase Inhibitor by Alveolar Inflammatory Cells from Smoking Patients with or without Emphysema
1993
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
The three heavy-chain precursors for the inter-α-inhibitor family in mouse: new members of the multicopper oxidase protein group with differential transcription in liver and brain
1995
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Host-Bacterial Mutualism in the Human Intestine
2005 StandoutScience
NUTRITIONAL IMPACT OF PRE- AND PROBIOTICS AS PROTECTIVE GASTROINTESTINAL ORGANISMS
2002
Impaired TGF-β Responses in Peripheral T Cells of Gαi2−/− Mice
2005 StandoutNobel
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms
2004
EXPRESSION OF INTER-α INHIBITOR RELATED PROTEINS IN KIDNEYS AND URINE OF HYPEROXALURIC RATS
2001
Systemic Interactions between Inhaled Ultrafine Particles and Endotoxin
2002
Normal and abnormal aspects of proteinuria
1986
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Introduction to the human gut microbiota
2017 Standout
Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to sepharose
1978 Standout
Effects of Heparin on the Inhibitory Activities of Human Urinary Trypsin Inhibitor (Ulinastatin) on Trypsin, Chymotrypsin and Leukocyte Elastase
1993
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance
2000
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet
2010
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug Development
1975
Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease
2006
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials
1999
Works of C Mizon being referenced
A Proteoglycan Related to the Urinary Trypsin Inhibitor (UTI) Links the two Heavy Chains of Inter-α-Trypsin Inhibitor
1989
The chondroitin sulfate chain of bikunin‐containing proteins in the inter‐α‐inhibitor family increases in size in inflammatory diseases
2001
Development of an enzyme-linked immunosorbent assay for human plasma inter-α-trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains
1996
Plasma proteins immunologically related to inter-α-trypsin inhibitor
1988
Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease
1997
The Heavy Chains of Human Plasma Inter-α-Trypsin Inhibitor: Their Isolation, Their Identification by Electrophoresis and Partial Sequencing. Differential Reactivity with Concanavalin A
1992
Urinary Bikunin Determination Provides Insight into Proteinase/Proteinase Inhibitor Imbalance in Patients with Inflammatory Diseases
2002
Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease
1995
Oxidative Inactivation of α 1 -Proteinase Inhibitor by Alveolar Macrophages from Healthy Smokers Requires the Presence of Myeloperoxidase
1991
Effects of Inter- α -inhibitor in Experimental Endotoxic Shock and Disseminated Intravascular Coagulation
1997
Human Urinary Proteinase Inhibitor: Inhibitory Properties and Interaction with Bovine Trypsin
1985
Rapid sodium dodecyl sulfat/polyacrylamide gel electrophoresis of urinary proteins.
1980
The major human urinary trypsin inhibitor is a proteoglycan
1986
Isolation of a human urinary trypsin inhibitor
1982
Urinary protein determination using Coomassie Brilliant Blue in the presence of sodium dodecyi sulphate
1984
[Determination of the inhibitory activity of some new substituted theophyllines on the specific phosphodiesterase of cyclic nucleotides].
1972
The Effect of the Glycosaminoglycan Chain Removal on some Properties of the Human Urinary Trypsin Inhibitor
1987